Abstract
Malaria is one of the main infectious diseases in tropical developing countries and represents high morbidity and mortality rates nowadays. The principal etiological agent P. falciparum is transmitted through the bite of the female Anopheles mosquito. The issue has escalated due to the emergence of resistant strains to most of the antimalarials used for the treatment including Chloroquine, Sulfadoxine-Pyrimethamine, and recently Artemisinin derivatives, which has led to diminished effectiveness and by consequence increased the severity of epidemic outbreaks. Due to the lack of effective compounds to treat these drug-resistant strains, the discovery or development of novel anti-malaria drugs is important. In this context, one strategy has been to find inhibitors of enzymes, which play an important role for parasite survival. Today, promising results have been obtained in this regard, involving the entire P. falciparum metabolism. These inhibitors could serve as leads in the search of a new chemotherapy against malaria. This review focuses on the achievements in recent years with regard to inhibition of enzymes used as targets for drug design against malaria.
Keywords: Malaria, Plasmodium falciparum, enzyme inhibition, drug design.
Graphical Abstract
Current Protein & Peptide Science
Title:Targeting Plasmodium Metabolism to Improve Antimalarial Drug Design
Volume: 17 Issue: 3
Author(s): Lluvia Ríos-Soto, Alfredo Téllez-Valencia, Mara Campos-Almazán, Jaime De Lira-Sánchez, Jessica Hernández-Rivera, Mónica Valdez-Solana, Marcelo Gómez Palacio-Gastélum, Jorge Cisneros-Martínez, Edna Méndez-Hernández, Claudia Avitia-Domínguez, Marie Sarabia-Sanchez, Alejandro Favela-Candia, Artemisa Luevano-De la Cruz, Alejandra Vázquez-Raygoza, Miriam Aguirre-Raudry, Irene Betancourt-Conde and Erick Sierra-Campos
Affiliation:
Keywords: Malaria, Plasmodium falciparum, enzyme inhibition, drug design.
Abstract: Malaria is one of the main infectious diseases in tropical developing countries and represents high morbidity and mortality rates nowadays. The principal etiological agent P. falciparum is transmitted through the bite of the female Anopheles mosquito. The issue has escalated due to the emergence of resistant strains to most of the antimalarials used for the treatment including Chloroquine, Sulfadoxine-Pyrimethamine, and recently Artemisinin derivatives, which has led to diminished effectiveness and by consequence increased the severity of epidemic outbreaks. Due to the lack of effective compounds to treat these drug-resistant strains, the discovery or development of novel anti-malaria drugs is important. In this context, one strategy has been to find inhibitors of enzymes, which play an important role for parasite survival. Today, promising results have been obtained in this regard, involving the entire P. falciparum metabolism. These inhibitors could serve as leads in the search of a new chemotherapy against malaria. This review focuses on the achievements in recent years with regard to inhibition of enzymes used as targets for drug design against malaria.
Export Options
About this article
Cite this article as:
Ríos-Soto Lluvia, Téllez-Valencia Alfredo, Campos-Almazán Mara, De Lira-Sánchez Jaime, Hernández-Rivera Jessica, Valdez-Solana Mónica, Gómez Palacio-Gastélum Marcelo, Cisneros-Martínez Jorge, Méndez-Hernández Edna, Avitia-Domínguez Claudia, Sarabia-Sanchez Marie, Favela-Candia Alejandro, Luevano-De la Cruz Artemisa, Vázquez-Raygoza Alejandra, Aguirre-Raudry Miriam, Betancourt-Conde Irene and Sierra-Campos Erick, Targeting Plasmodium Metabolism to Improve Antimalarial Drug Design, Current Protein & Peptide Science 2016; 17 (3) . https://dx.doi.org/10.2174/1389203717999160226180353
DOI https://dx.doi.org/10.2174/1389203717999160226180353 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Immunossupressant and Organ Transplantation: Immunophilins Targeting Agent and Alternative Therapies
Current Medicinal Chemistry Pharmacological Treatments for Cocaine Dependence: Is There Something New?
Current Pharmaceutical Design Role of ARBs in the Blood Hypertension Therapy and Prevention of Cardiovascular Events
Current Drug Targets The Problem of Atrial Fibrillation in Patients with Chronic Kidney Disease
Current Vascular Pharmacology Extracellular Matrix Remodeling in Hypertension
Current Hypertension Reviews Drugs Used to Treat Parkinsons Disease, Present Status and Future Directions
CNS & Neurological Disorders - Drug Targets Current Concepts in Gastric Motility in Diabetes Mellitus
Current Diabetes Reviews Cytokine and Nitric Oxide Production Following Severe Envenomation
Current Drug Targets - Inflammation & Allergy QT Prolongation and Anticancer Drugs: Is it a Cardiologist’s Worry? The Oncologist’s Point of View
Reviews on Recent Clinical Trials Single-dose Pharmacokinetics and Tolerability of Oral Delta-9- Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis
Drug Metabolism Letters TiO2-Nanowired Delivery of Mesenchymal Stem Cells Thwarts Diabetes- Induced Exacerbation of Brain Pathology in Heat Stroke: An Experimental Study in the Rat Using Morphological and Biochemical Approaches
CNS & Neurological Disorders - Drug Targets Tetramethoxyluteolin for the Treatment of Neurodegenerative Diseases
Current Topics in Medicinal Chemistry Ionophores as Potent Anti-malarials: A Miracle in the Making
Current Topics in Medicinal Chemistry Safety of Canagliflozin in Patients with Type 2 Diabetes
Current Drug Safety Clinical Efficacy of Remdesivir and Favipiravir in the Treatment of COVID-19 Patients: Scenario so far
Current Drug Research Reviews Nitric Oxide and Cyclic GMP Signaling Pathway as a Focus for Drug Development
Current Medicinal Chemistry Targeting Kinin Receptors for the Treatment of Neurological Diseases
Current Pharmaceutical Design Selection Criteria for Probiotics and Potential of Cereal Based Food Products as Novel Probiotic-Carriers
Current Nutrition & Food Science Design of Multifunctional Compounds for Cardiovascular Disease: From Natural Scaffolds to “Classical” Multitarget Approach
Current Medicinal Chemistry Diagnosis, Treatment, and New Developments in Preeclampsia
Current Women`s Health Reviews